M. Dey Et Al. , "Higher risk of short term COVID-19 vaccine adverse events in myositis patients with autoimmune comorbidities: results from the COVAD study," RHEUMATOLOGY , 2022
Dey, M. Et Al. 2022. Higher risk of short term COVID-19 vaccine adverse events in myositis patients with autoimmune comorbidities: results from the COVAD study. RHEUMATOLOGY .
Dey, M., Naveen, R., Nikiphorou, E., Sen, P., Saha, S., Lilleker, J. B., ... Agarwal, V.(2022). Higher risk of short term COVID-19 vaccine adverse events in myositis patients with autoimmune comorbidities: results from the COVAD study. RHEUMATOLOGY .
Dey, Mrinalini Et Al. "Higher risk of short term COVID-19 vaccine adverse events in myositis patients with autoimmune comorbidities: results from the COVAD study," RHEUMATOLOGY , 2022
Dey, Mrinalini Et Al. "Higher risk of short term COVID-19 vaccine adverse events in myositis patients with autoimmune comorbidities: results from the COVAD study." RHEUMATOLOGY , 2022
Dey, M. Et Al. (2022) . "Higher risk of short term COVID-19 vaccine adverse events in myositis patients with autoimmune comorbidities: results from the COVAD study." RHEUMATOLOGY .
@article{article, author={Mrinalini Dey Et Al. }, title={Higher risk of short term COVID-19 vaccine adverse events in myositis patients with autoimmune comorbidities: results from the COVAD study}, journal={RHEUMATOLOGY}, year=2022}